Basilea Pharmaceutica AG GAAP EPS of CHF 1.02, revenue of CHF 147.8M; initiates FY22 guida

Basilea Pharmaceutica AG GAAP EPS of CHF 1.02, revenue of CHF 147.8M; initiates FY22 guidance

Source link